Talcosis — VA Disability Rating (DC 6832)

Diagnostic Code 6832 · 38 CFR §4.97

What Is It?

Talcosis is a chronic interstitial lung disease caused by inhaling fine particles of talc, a hydrated magnesium silicate. The particles lodge in the alveoli and small airways, trigger a chronic inflammatory response, and over years produce scarring that stiffens the lungs and impairs gas exchange. Three main exposure routes are recognized: pure talc inhalation (industrial talc handling, certain ceramics and rubber operations), talc inhalation from contaminated mineral dusts (talc often appears alongside asbestos or silica), and pulmonary granulomatous disease from intravenous injection of crushed pills that contain talc as a binder. Veterans most often encounter talcosis through industrial dust exposure during certain MOSs — supply handlers working with talc-based powders, ceramics or rubber maintenance work, and certain manufacturing roles. Symptoms develop gradually: progressive shortness of breath on exertion, dry cough, chest tightness, and reduced exercise tolerance. Talcosis is a pneumoconiosis, so it belongs to DC 6832 — 38 CFR § 4.97 titles that code "Pneumoconiosis (silicosis, anthracosis, etc.)," and the "etc." is what carries talc, coal, kaolin and the other mineral dusts the schedule does not list by name. Where a rating decision prefers to build an analogous code, § 4.20 and § 4.27 produce a hyphenated number ending in 6832; the criteria are the same either way, because DC 6832 sits inside the General Rating Formula for Interstitial Lung Disease that governs DC 6825 through DC 6833. DC 6835 is not this condition at all: § 4.97 assigns it to coccidioidomycosis — Valley fever — a fungal infection rated on the separate Mycotic Lung Disease formula, which counts fever, weight loss, night sweats and hemoptysis rather than lung function.

Rating Criteria

Evidence Needed

A high-resolution CT scan of the chest is the most useful imaging — it shows the characteristic interstitial markings, often with small nodular opacities and sometimes confluent fibrotic areas. Pulmonary function tests with spirometry, lung volumes, and DLCO measurement establish the rating tier directly. A six-minute walk test or formal cardiopulmonary exercise testing supports the higher tiers when symptoms outpace what resting PFTs show. A lung biopsy showing birefringent talc particles on polarized microscopy can confirm the diagnosis in uncertain cases. Occupational and military exposure history from service treatment records, MOS records, and lay statements describing the exposure events all build the nexus. A pulmonologist diagnosis distinguishing talcosis from silicosis, asbestosis, and other interstitial diseases closes the case.

C&P Exam Tips

Bring the chest CT, PFT reports including DLCO, and any exercise testing. The rating tier is set by FVC, DLCO (SB) or maximum exercise capacity; FEV-1 has no place in the interstitial formula, so a spirometry-only report cannot establish a tier. Make sure FVC and DLCO are both in the record. If exercise tolerance is severely limited but resting PFTs do not reflect that, request a formal cardiopulmonary exercise test. Describe what you can no longer do that you used to do, and quantify breath limitations. Mention any oxygen use. Bring the exposure history in writing so the examiner does not have to reconstruct it from memory.

How to File

File VA Form 21-526EZ listing talcosis under DC 6832 and reference 38 CFR § 4.97. Attach the chest CT, the PFT report, exercise testing if performed, any biopsy results, and the exposure history with MOS records and lay statements. If the exposure pattern suggests mixed dust disease (talc combined with silica or asbestos), say so and name DC 6833 as well; § 4.96(a) has the rater assign one evaluation under the predominant code rather than combining them. File cor pulmonale and recurrent respiratory infection complications as separate secondary claims when documented.

Common Mistakes

Filing without a DLCO measurement, which often drives the rating tier even when spirometry numbers are near-normal Not requesting formal exercise testing when symptoms exceed what resting PFTs suggest Treating talc exposure as benign because the substance is associated with cosmetics or food-grade applications — industrial-grade talc is a known pneumoconiosis hazard Missing the mixed dust pneumoconiosis pathway when the exposure history suggests coexisting silica or asbestos exposure

Frequently Asked Questions

How is talcosis different from silicosis?

Both are pneumoconioses, both are rated under DC 6832, both sit inside the same General Rating Formula for Interstitial Lung Disease, and the rating tiers are therefore identical. The differences are in the causative dust (talc versus crystalline silica), the imaging pattern (talcosis often shows more diffuse interstitial markings versus the upper-lobe nodular pattern characteristic of silicosis), and the cancer risk profile (silicosis is a more established lung cancer risk than talcosis). The diagnosis is confirmed by exposure history plus imaging plus, when uncertain, lung biopsy with polarized microscopy.

Can cosmetic talc exposure cause talcosis?

Pulmonary talcosis from cosmetic talc (baby powder, body powder) is rare in adults but has been documented, particularly with sustained heavy use. The more common military-relevant exposure routes are industrial talc handling, ceramics and rubber operations, and mixed dust environments where talc appears alongside silica or asbestos. The nexus opinion needs to connect the specific exposure pattern to the imaging and functional findings.

Will my rating drop if my PFT numbers improve?

Talcosis is a progressive scarring disease; PFT numbers do not typically improve. Short-term fluctuations from effort or technique are not a basis for rating reduction under 38 CFR §3.344. The protection rules favor keeping the existing rating unless an improvement is sustained, material, and supported by clinical findings consistent with reversed disease — which is rare for any interstitial lung disease.